Runway Growth Finance Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw strong investment income growth, portfolio expansion via the SWK acquisition, and continued focus on diversification and disciplined capital allocation. Despite market volatility and realized losses from restructurings, fundamentals remain robust and dividend coverage is expected to exceed 100% for the year.
-
Q1 2026 saw lower investment income and NAV, but the SWK acquisition diversified the portfolio and is expected to be accretive to EPS by Q3. Non-accruals impacted risk ratings and earnings, but liquidity remains strong and a $15M share repurchase program was launched.
Fiscal Year 2025
-
Q4 2025 saw lower investment income and net income sequentially, but portfolio activity remained robust with 7 new investments and a strong pipeline for 2026. The pending SWK Holdings acquisition is set to diversify assets and enhance healthcare exposure, while capital optimization and disciplined risk management continue.
-
Q3 2025 saw higher investment income and net investment income, with strong origination activity and a focus on portfolio diversification. The announced SWK Holdings acquisition is expected to scale assets, boost healthcare exposure, and be accretive post-close.
-
A definitive merger agreement has been reached to acquire a specialty finance company focused on healthcare and life sciences, increasing portfolio diversification and scale. The $220 million NAV-for-NAV, tax-free merger is expected to close by early 2026, pending approvals.
-
Q2 2025 saw investment income of $35.1M and net investment income of $13.9M, with a focus on portfolio optimization, diversification, and new product offerings. NAV per share rose to $13.66, and liquidity remains strong. Management expects a brighter outlook for 2026, prioritizing quality and diversification.
-
Q1 2025 saw $35.4M in investment income and $15.6M net investment income, with portfolio value and NAV per share declining slightly. Management remains focused on disciplined underwriting, liquidity, and selective growth, while launching a $25M stock repurchase and maintaining a stable dividend.
Fiscal Year 2024
-
Q4 2024 saw strong portfolio performance with $33.8M in investment income and improved credit quality. The advisor's acquisition by BC Partners Credit enhances origination and diversification, while a new dividend policy aims for stability. NAV per share rose 3% sequentially.
-
Q3 2024 saw $75.3M in new investments, stable credit quality, and a portfolio fair value of $1.07B. The advisor's acquisition by BC Partners is expected to accelerate originations and diversify offerings, while the board paused supplemental dividends to focus on NAV growth.
-
Q2 2024 saw $75.5M in new investments, $34.2M in investment income, and a NAV per share of $13.14. Prepayments are expected to total $200–$300M in H2, supporting dividend coverage and portfolio redeployment. The portfolio remains high quality, with a disciplined credit approach.